RAD.AX - Radiopharm Theranostics Limited

ASX - ASX Delayed price. Currency in AUD
Currency in AUD

Valuation measures4

Market cap (intra-day) 42.41M
Enterprise value -22.28M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.69
Enterprise value/revenue -2.52k
Enterprise value/EBITDA 1.07

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-13.79%
S&P500 52-week change 314.65%
52-week high 30.2500
52-week low 30.1000
50-day moving average 30.1599
200-day moving average 30.1424

Share statistics

Avg vol (3-month) 3342.08k
Avg vol (10-day) 3241.66k
Shares outstanding 5339.31M
Implied shares outstanding 6N/A
Float 8184.13M
% held by insiders 165.21%
% held by institutions 11.06%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 June 2022
Most-recent quarter (mrq)31 Dec 2022


Profit margin 0.00%
Operating margin (ttm)-554.30%

Management effectiveness

Return on assets (ttm)N/A
Return on equity (ttm)N/A

Income statement

Revenue (ttm)4.27M
Revenue per share (ttm)0.02
Quarterly revenue growth (yoy)17,757,642.19%
Gross profit (ttm)8.83k
EBITDA -20.41M
Net income avi to common (ttm)-25.58M
Diluted EPS (ttm)-0.0500
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)24.25M
Total cash per share (mrq)0.07
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)2.05
Book value per share (mrq)0.19

Cash flow statement

Operating cash flow (ttm)-17.13M
Levered free cash flow (ttm)N/A